Featured Research

from universities, journals, and other organizations

Subtypes of malignant melanoma - invisible yet fatal

Date:
November 4, 2013
Source:
University of Ulm
Summary:
Scientists have discovered a diagnostic algorithm to distinguish two subtypes of malignant melanoma. Desmoplastic and spindle cell melanoma may look alike – they often resemble little scars or retractions of the skin – but differ in prognosis and therapeutic options. Sometimes even routine histology is not decisive because of partly overlapping features. The new algorithm, a combination of the biomarkers Melan A and trichrome, allows a diagnostic distinction of the subtypes.

Trichrome. Scientists have identified 5 specific markers for spindle cell melanoma and 4 for desmoplastic melanoma. In more than 90 percent of the assessed cases, a combination of the biomarkers Melan A and trichrome allowed a diagnostic distinction.
Credit: University of Ulm

Scientists of the University of Ulm and Columbia University have discovered a diagnostic algorithm to distinguish two subtypes of malignant melanoma. Desmoplastic and spindle cell melanoma may look alike -- they often resemble little scars or retractions of the skin -- but differ in prognosis and therapeutic options. Sometimes even routine histology is not decisive because of partly overlapping features. The new algorithm, a combination of the biomarkers Melan A and trichrome, allows a diagnostic distinction of the subtypes.

A 48-year-old patient sees her dermatologist because of a scar-like lesion on her forehead. Even the well-trained physician has trouble to diagnose the lesion: The scar on the woman's forehead is a rare type of skin cancer -- a desmoplastic melanoma. The tumor bears resemblance to the far more dangerous spindle cell melanoma. And sometimes even routine histology is not decisive because of overlapping features. Scientists of the University of Ulm (Germany) and Columbia University have now identified a new algorithm to distinguish the two subtypes of malignant melanoma. The tumors may look alike but differ clinically in prognosis and therapeutic options. The pathologist Dr. Jochen Lennerz, M.D. and the PhD-candidate Stephanie Weissinger have published their findings in the journal "Modern Pathology."

So far, the melanoma-subtypes have been studied inadequately: As non-pigmented tumors they can be clinically invisible and are rarely discovered or often mistaken for little scars or retractions of the skin. "Spindle cell melanoma, that can occur at any site of the body, tend to spread and might be fatal. The prognosis of desmoplastic melanoma is much better," says pathologist Lennerz. In order to distinguish the two subtypes, the researchers have tested 38 samples for 50 well-known biomarkers. They have conducted several molecular genetic analyses (gene expression profiling, fluorescent in situ hybridization, Immunohistochemistry, genotyping). Overall, the scientists have identified 5 specific markers for spindle cell melanoma and 4 for desmoplastic melanoma. In more than 90 percent of the assessed cases, a combination of the biomarkers Melan A and trichrome allowed a diagnostic distinction. "A few biomarkers are sufficient to distinguish the subtypes and some of the markers were really obvious," explains Stephanie Weissinger.

Professor David N. Silvers, M.D. and his research group at Columbia University have provided samples of their independent patient cohort to verify the algorithm. A new technique of gene expression profiling for small and rare tumor-samples is a side-product of the study. In addition, the scientists have identified markers with therapeutic relevance. Quite remarkably, the paper's first author, Stephanie Weissinger, is a trained nurse and a medical student at the University of Ulm. She has substantially contributed to the study before even finishing her PhD thesis. Jochen Lennerz's work has been funded by the Else Krφner-Fresenius Foundation.


Story Source:

The above story is based on materials provided by University of Ulm. Note: Materials may be edited for content and length.


Journal Reference:

  1. Stephanie E Weissinger, Philipp Keil, David N Silvers, Beate M Klaus, Peter Mφller, Basil A Horst, Jochen K Lennerz. A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma. Modern Pathology, 2013; DOI: 10.1038/modpathol.2013.162

Cite This Page:

University of Ulm. "Subtypes of malignant melanoma - invisible yet fatal." ScienceDaily. ScienceDaily, 4 November 2013. <www.sciencedaily.com/releases/2013/11/131104112406.htm>.
University of Ulm. (2013, November 4). Subtypes of malignant melanoma - invisible yet fatal. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2013/11/131104112406.htm
University of Ulm. "Subtypes of malignant melanoma - invisible yet fatal." ScienceDaily. www.sciencedaily.com/releases/2013/11/131104112406.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) — An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) — Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) — Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) — It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins